Tempus AI, Inc.

NASDAQ:TEM

Medical - Healthcare Information Services

Healthcare
$63.62 -3.50%

-$1.77 today

Market cap
$11.28B
Beta
3.62
P/E (TTM)
-28.8
EPS (TTM)
-$1.69
52W Low $41.73High $104.32

Volume 5.35M

Average 6.17M

TEM Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Tempus AI, Inc.NASDAQ: TEM

Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026

Capital expenditures dips below year-ago levels

Q3 FY2026 capital expenditures of $2.51M (cash outflow) fell 68.9% year over year, behind the +3.8% change in trailing-twelve-month capital expenditures. Sequentially, it fell 77.4% from the prior quarter. Over 3 fiscal years it compounded at +14.1% a year.

Context

  • Capital expenditures amounted to 2.1% of revenue in FY2025, down 1.0 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -68.9% toward the trailing-twelve-month pace of +3.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$2.51M-77.4% QoQ
Last fiscal yearDec 2025
-$27.27M+23.3% YoY
LTMSep 2026
-$30M+3.8% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-68.9%——
1 year+23.3%——
3-year CAGR+14.1%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(27.27M) USD
Year-over-year change
-23.3%

Capital Expenditures vs competitors

How TEM compares with its peers on the latest reported figures

  • TEM's LTM Sep 2026 capital expenditures of $30M is the 6th largest of the 11 companies compared; the peer median is $44.04M.
  • Its year-over-year change of +3.8% is the 7th highest of 10, against a peer median of +17.1%.
  • Capital expenditures amounts to 2.0% of revenue for TEM, versus a peer median of 4.2%.
TEM Competitors Peer median
Capital Expenditures for TEM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DGXQuest Diagnostics IncorporatedLTM Sep 2026$576M +17.1%+9.3%4.9%
QGENQiagen N.V.LTM Jun 2026$206.77M +15.7%+10.4%9.8%
NTRANatera, Inc.LTM Jun 2026$156.54M +90.6%+30.6%5.8%
ILMNIllumina, Inc.LTM Jun 2026$156M +26.8%-19.7%3.5%
GHGuardant Health, Inc.LTM Sep 2026$58.67M +49.2%-14.6%4.6%
TEMTempus AI, Inc.LTM Sep 2026$30M +3.8%+14.1%2.0%
NEONeoGenomics, Inc.LTM Jun 2026$29.4M -11.5%-4.4%3.8%
MYGNMyriad Genetics, Inc.LTM Mar 2026$23.2M -21.1%-29.9%2.8%
BLLNBillionToOne, Inc.LTM Jun 2026$12.18M ——3.1%
PSNLPersonalis, Inc.LTM Mar 2026$5.19M +29.3%-55.1%8.0%
BDSXBiodesix, Inc.LTM Mar 2026$411K -87.6%-51.5%0.4%
Peer median (excluding TEM) $44.04M+17.1%-14.6%4.2%

Competitors are the stored peer set for TEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(259.19M)(289.81M)(214.12M)(705.81M)(245.03M)
Depreciation & Amortization23.88M30.41M33.33M37.25M102.32M
Deferred Income Tax0000(52.67M)
Stock-Based Compensation559K00534.14M124.75M
Change in Working Capital14.55M71.82M(37.84M)(37.8M)(178.55M)
Accounts Receivables4.75M(8.2M)(7.35M)(61.04M)(90.4M)
Inventory14.65M(1.31M)(6.56M)(9.54M)(3.37M)
Accounts Payables(30.47M)(7.92M)(23.36M)(23.85M)(7.24M)
Other Working Capital25.63M89.25M(564K)56.63M(77.54M)
Other Non-Cash Items8.22M19.38M4.28M(16.82M)31.08M
Operating Cash Flow(211.98M)(168.2M)(214.34M)(189.05M)(218.09M)
Capital Expenditures(11.77M)(18.38M)(34.61M)(22.12M)(27.27M)
Acquisitions (Net)(5.96M)(39.56M)(5.71M)(95.19M)(376.67M)
Purchases of Investments000(36.18M)(2.74M)
Sales of Investments00023.1M8.32M
Other Investing Activities(4M)000(6.22M)
Investing Cash Flow(21.72M)(57.94M)(40.31M)(130.39M)(398.36M)
Debt Repayment(796K)170.25M82.59M0735.76M
Common Stock Issued000381.95M195.5M
Common Stock Repurchased00(3.6M)0(3.04M)
Dividends Paid(5.63M)(5.63M)(5.63M)(5.63M)0
Other Financing Activities(4.51M)(5.43M)(698K)(79.5M)(44.1M)
Financing Cash Flow(2.04M)251.39M117.55M494.33M884.12M
Effect of Forex Changes(3K)17K(19K)336K(62K)
Net Change in Cash(235.75M)25.27M(137.12M)175.23M267.62M
Free Cash Flow(223.75M)(186.58M)(248.95M)(211.17M)(245.36M)

Tempus AI, Inc.

NASDAQ:TEM

Intrinsic Alpha fair value

Locked

Current Price

$63.62

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.